Innoviva to Report Third Quarter Financial Results on October 25 at 5:00 p.m. EDT
October 18 2017 - 4:05PM
Business Wire
Innoviva, Inc. (NASDAQ: INVA) announced today that it will
report financial results for the third quarter ended September 30,
2017 after market close on Wednesday, October 25, 2017. Following
the earnings release, Innoviva management will host a webcast and
conference call at 5:00 p.m. EDT/2:00 p.m. PDT to discuss the
financial results and provide a corporate update.
To participate in the live call, dial (877) 837-3908 from the
U.S., or (973) 890-8166 for international callers, and enter
Conference ID: 2272916. A live webcast of the call will be
available at: https://edge.media-server.com/m6/p/abjk7qxo or from
the investor relations section of the company website at
www.inva.com and will be archived for 30 days. A telephone replay
of the call will be available for seven days, through November 1,
by dialing (404) 537-3406.
About Innoviva
Innoviva is focused on bringing compelling new medicines to
patients in areas of unmet need by leveraging its significant
expertise in the development, commercialization and financial
management of bio-pharmaceuticals. Innoviva's portfolio
is anchored by the respiratory assets partnered with Glaxo
Group Limited (GSK), including RELVAR®/BREO® ELLIPTA® and
ANORO® ELLIPTA®, which were jointly developed
by Innoviva and GSK. Under the agreement with
GSK, Innoviva is eligible to receive associated royalty
revenues from RELVAR®/BREO® ELLIPTA®, ANORO® ELLIPTA®. In
addition, Innoviva retains a 15 percent economic interest
in future payments made by GSK for earlier-stage programs partnered
with Theravance BioPharma, Inc., including the closed triple
combination therapy for Chronic Obstructive Pulmonary Disease
(COPD). For more information, please
visit Innoviva's website at www.inva.com.
ANORO®, RELVAR®, BREO® and ELLIPTA® are trademarks of the
GlaxoSmithKline group of companies.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171018005053/en/
Innoviva, Inc.Eric d'EsparbesSenior Vice President and Chief
Financial Officer650-238-9640investor.relations@inva.com
Innoviva (NASDAQ:INVA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Innoviva (NASDAQ:INVA)
Historical Stock Chart
From Apr 2023 to Apr 2024